Christophe Hubert
I CEO
Christophe Hubert joined EnnoDC (formerly LinKinVax) in March 2024 as CEO to help refocus the business.
He is an international business executive and biotech entrepreneur, with over 25 years’ experience in the pharmaceutical and biotech industry, both in established pharmaceutical companies and biotech start-ups.
Prior to joining EnnoDC he served as SVP of Asia Merck and as the President of Théramex, the global specialty pharmaceutical company focused on women’s health.
Other prior roles include SVP of Teva Europe and the founder and President of three biotech companies.
Christophe has a Bachelor of Science from ESCEM Group Ecole Supérieure de Commerce et de Management de Tours, an MBA form Indiana State University in the US and a Certificate in AI from MIT Sloan School of Management.
